FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT07353827 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07353827
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy

Start date: 2026-02-01
Primary completion: 2027-08-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.